NDTP OTC
NDT Pharmaceuticals Inc.
1W: -35.9%
1M: -39.2%
3M: -44.5%
YTD: -84.0%
1Y: -78.2%
3Y: -94.8%
5Y: +121328.6%
$0.26
+0.01 (+2.00%)
Weekly Expected Move ±23.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$17K
+33.7% ▲
Net Income
-$17K
+78.9% ▲
EPS (Diluted)
$-0.00
+80.0% ▲
EBITDA
-$17K
-118.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2015 | FY2016 | FY2017 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $87K | $2K | $1K | $25K | $17K |
| Operating Expenses | $87K | $2K | $1K | $25K | $17K |
| Operating Income | -$87K | -$2K | -$1K | -$25K | -$17K |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$87K | -$2K | -$1K | -$79K | -$17K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$87K | -$2K | -$1K | -$79K | -$17K |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-0.29 | $-0.01 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$87K | -$2K | -$1K | $89K | -$17K |
| Shares Outstanding | 302450 | 302450 | 302450 | 160M | 160M |